# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-054210
Filing Date
2020-11-16
Accepted
2020-11-16 17:02:01
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nvus-10q_20200930.htm | 10-Q | 2410669
2 | EX-31.1 | nvus-ex311_6.htm | EX-31.1 | 11430
3 | EX-31.2 | nvus-ex312_9.htm | EX-31.2 | 11493
4 | EX-32.1 | nvus-ex321_8.htm | EX-32.1 | 7498
5 | EX-32.2 | nvus-ex322_7.htm | EX-32.2 | 7869
| Complete submission text file | 0001564590-20-054210.txt |  | 7256778

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE DOCUMENT | nvus-20200930.xml | EX-101.INS | 1336286
7 | XBRL TAXONOMY EXTENSION SCHEMA | nvus-20200930.xsd | EX-101.SCH | 61836
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nvus-20200930_cal.xml | EX-101.CAL | 47474
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nvus-20200930_def.xml | EX-101.DEF | 176376
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nvus-20200930_lab.xml | EX-101.LAB | 400659
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nvus-20200930_pre.xml | EX-101.PRE | 315607

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 201318143
SIC: 2834 Pharmaceutical Preparations